Discovery of miRNAs affected by epigenetics in cancer
Author Information
Author(s): Toby Hulf, Tennille Sibbritt, Erik D Wiklund, Saul Bert, Dario Strbenac, Aaron L Statham, Mark D Robinson, Susan J Clark
Primary Institution: Garvan Institute of Medical Research
Hypothesis
Epigenetically deregulated miRNAs in cancer would show differential expression at the primary transcript level, differential mature miRNA expression, and associated changes in epigenetic marks.
Conclusion
The study demonstrates that changes in primary miRNA transcription levels can indicate local epigenetic modifications linked to mature miRNA expression changes.
Supporting Evidence
- The study identified miR-205, miR-21, and miR-196b as epigenetically repressed in prostate cancer cells.
- MiR-615 was found to be epigenetically activated in the same context.
- A high proportion of upregulated and downregulated miRNAs showed overlap with at least one epigenetic mark.
Takeaway
The researchers found that some tiny molecules in our cells, called miRNAs, can be turned on or off by changes in their DNA, which can help us understand cancer better.
Methodology
An integrative approach combining primary transcription, genome-wide DNA methylation, and H3K9Ac marks with microRNA expression was used to identify epigenetically modified miRNAs.
Potential Biases
Immunoprecipitation techniques can be affected by antibody sensitivity, and treatment with demethylating drugs may uncover false positives.
Limitations
The study's methods may be biased towards regions of high CpG content, leading to potential false negatives.
Participant Demographics
Normal prostate epithelial (PrEC) and prostate cancer (LNCaP) cells were used as a model system.
Statistical Information
P-Value
1.2E-05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website